- Medicines and Healthcare products Regulatory Agency
- Part of:
- Regulatory guidance for medical devices
- 13 May 2016
- Last updated:
- 6 October 2017, see all updates
Guidance for notified bodies: devices which incorporate an ancillary medicinal substance
NOTE: This is guidance that was first published in 2011 on the previous MHRA website. It is currently being updated and will be published shortly.
This Guidance is for Notified Bodies and their client companies wishing to consult the Medicines and Healthcare products Regulatory Agency (MHRA) with regard to the ancillary medicinal substance incorporated in a medical device.
Published: 13 May 2016
Updated: 6 October 2017
- Updated attachment
- First published.